A string of serious setbacks for possible treatments may be eroding researchers' -- and investors' -- confidence.
Unlike biotechs, many of these companies are pouring money into share buybacks -- instead of their long-term pipelines.
The only explanation for recent stock action is market players following others blindly. The bulls just have to hope analysts don't think this is National Lemming Week.
Investors are digesting a slew of earnings as they await jobless claims data.
With the sector stocks at all-time highs, analysts fear that investors will sell at first sign of trouble.
The sector's revaluation is on, and these names in particular have made some stunning moves.
Investors can still find some compelling valuations among large-cap drug companies even as major stock indices hit new highs.
The market's run is relentless, so better find solid old growth stocks that aren't too expensive.
VIDEO ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
TOP STOCKS
The market's cheap money addiction is laid bare. No one knows how it will end.
MARKET DISPATCHES
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
FRUGAL COOL
Starting Monday, this site is joining forces with MSN Money Smart Spending. Here's why.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
SMART SPENDING
Yes, sometimes retail therapy has a place. Just try to be aware of shopping to beat the blues, and don't overspend.
SMART TAXES
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.
